Using C-reactive protein to assess cardiovascular disease risk

被引：34

作者：

Shishehbor, MH

Bhatt, DL

Topol, EJ

机构：

[1] Cleveland Clin Fdn, Dept Cardiovasc Med, Cleveland, OH 44195 USA

[2] Cleveland Clin Fdn, Dept Internal Med, Cleveland, OH 44195 USA

来源：

CLEVELAND CLINIC JOURNAL OF MEDICINE | 2003年 / 70卷 / 07期

关键词：

D O I：

10.3949/ccjm.70.7.634

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

C-reactive protein (CRP), a marker of inflammation, is directly involved in atherogenesis, and elevated CRP levels (as measured by highly sensitive assays) are associated with increased cardiovascular risk. We welcome the recent joint guidelines on CRP testing from the Centers for Disease Control and Prevention and the American Heart Association; however, whereas the guidelines suggest measuring the CRP level only in patients at intermediate risk, we advocate measuring it as well in-patients at high risk.

引用

页码：634 / 640

页数：7

共 51 条

[1] Prospective study of C-reactive protein, homocysteine, and plasma lipid levels as predictors of sudden cardiac death [J].

Albert, CM ;

Ma, J ;

Rifai, N ;

Stampfer, MJ ;

Ridker, PM .

CIRCULATION, 2002, 105 (22) :2595-2599

[2] Effect of statin therapy on C-reactive protein levels - The Pravastatin Inflammation/CRP Evaluation (PRINCE): A randomized trial and cohort study [J].

Albert, MA ;

Danielson, E ;

Rifai, N ;

Ridker, PM .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (01) :64-70

[3] Scientific and therapeutic advances in antiplatelet therapy [J].

Bhatt, DL ;

Topol, EJ .

NATURE REVIEWS DRUG DISCOVERY, 2003, 2 (01) :15-28

[4] The arterial inflammation hypothesis [J].

Bhatt, DL ;

Topol, E .

ARCHIVES OF INTERNAL MEDICINE, 2002, 162 (19) :2249-2250

[5] Need to test the arterial inflammation hypothesis [J].

Bhatt, DL ;

Topol, EJ .

CIRCULATION, 2002, 106 (01) :136-140

[6] Elevated levels of C-reactive protein at discharge in patients with unstable angina predict recurrent instability [J].

Biasucci, LM ;

Liuzzo, G ;

Grillo, RL ;

Caligiuri, G ;

Rebuzzi, AG ;

Buffon, A ;

Summaria, F ;

Ginnetti, F ;

Fadda, G ;

Maseri, A .

CIRCULATION, 1999, 99 (07) :855-860

[7]

Black HR, 1997, ARCH INTERN MED, V157, P2413

[8] Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure [J].

Chobanian, AV ;

Bakris, GL ;

Black, HR ;

Cushman, WC ;

Green, LA ;

Izzo, JL ;

Jones, DW ;

Materson, BJ ;

Oparil, S ;

Wright, JT ;

Roccella, EJ .

HYPERTENSION, 2003, 42 (06) :1206-1252

[9]

CLEEMAN JI, 1988, ARCH INTERN MED, V148, P36, DOI 10.1001/archinte.148.1.36

[10] Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].

Cleeman, JI ;

Grundy, SM ;

Becker, D ;

Clark, LT ;

Cooper, RS ;

Denke, MA ;

Howard, WJ ;

Hunninghake, DB ;

Illingworth, DR ;

Luepker, RV ;

McBride, P ;

McKenney, JM ;

Pasternak, RC ;

Stone, NJ ;

Van Horn, L ;

Brewer, HB ;

Ernst, ND ;

Gordon, D ;

Levy, D ;

Rifkind, B ;

Rossouw, JE ;

Savage, P ;

Haffner, SM ;

Orloff, DG ;

Proschan, MA ;

Schwartz, JS ;

Sempos, CT ;

Shero, ST ;

Murray, EZ .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497

← 1 2 3 4 5 6 →